Response of pharma.be to the Call for Evidence on the Biotech Act Pharma.be strongly supports the ambition to foster a world-class innovation environment for biotechnologies. To make the EU more attractive for researching, developing and manufacturing new technologies, simplify and safeguard a robust IP framework.
AGL
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE
Trade union · Belgium · EU Transparency Register 25571625843-29
1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #861 by legislative files engaged — a count of participation, not a measure of influence.
1.5
declared lobbying FTE
self-declared
€400K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2011
in the register since
Declares membership of
- pharma.be is lid van EFPIA, de Europese geneesmiddelenfederatie.
- pharma.be is lid van IFPMA, de Internationale Federatie van Farmaceutische Producenten en Associaties
- pharma.be is lid van AESGP, Association of the European Self-Medication Industry
- pharma.be is lid van Animal Health Europe
- de vereniging die de fabrikanten van diergeneesmiddelen
- vaccins en andere diergezondheidsproducten in Europa vertegenwoordigt
- pharma.be is lid van Health for Animals, deze vereniging vertegenwoordigt de sector diergezondheid: fabrikanten van g…
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Trade and business associations
- Registered as
- Algemene vereniging van de Geneesmiddelenindustrie (pharma.be)
- Head office
- Brussel, Belgium
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track ASSOCIATION in PolicySpeak: request access →
Work at ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE? so we know who speaks for it.
Their record over time
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE filed 1 position on 11 Jun 2025, across 1 of the 326 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.